-
Omeros' Narsoplimab Associated With Improvement In Organ Function In Stem Cell Transplant Patients
Monday, June 14, 2021 - 12:45pm | 315Omeros Corporation (NASDAQ: OMER) has announced the presentation of data on organ function improvement from its pivotal trial of narsoplimab for the treatment of hematopoietic stem cell transplant-associated thrombotic microangiopathy (HSCT-TMA). Data were shared at the European...
-
Moderna Hires Harvard Stem Cell Researcher Jonathan Hoggatt as Director of Hematology: What You Need to Know
Friday, March 5, 2021 - 12:01pm | 471Moderna, Inc. (NASDAQ: MRNA), which shot to prominence with its coronavirus vaccine program, is beefing up its research and development team. What Happened: Jonathan Hoggatt, who was a principal faculty member at Harvard Stem Cell Institute, has joined Cambridge, Massachusetts-based Moderna...
-
Mesoblast Investors Shrug Off Positive Phase 2a Trial Data
Friday, April 1, 2016 - 11:22am | 210Shares of Mesoblast limited (ADR) (NASDAQ: MESO) were trading lower by more than 1 percent on Friday despite announcing earlier in the day positive Phase 2a trial data. Mesoblast is engaged in the development of adult stem cell technology platforms. The company announced that results from a...
-
Stem Cell Biotechs: A Frontrunner Emerges?
Saturday, April 21, 2012 - 12:33am | 1491Advances in modern medicine have been significant as scientists fight to prevent and cure the hosts of injuries and diseases plaguing mankind. Universities, government, pharmaceuticals and biotechs lead the way with new and improved mechanisms of countering these problems. Billions of...
-
Stem Cell Stock News Alert; Q&A with Stem Cell Company, Vitro Diagnostics, Inc. dba Vitro Biopharma
Friday, May 20, 2011 - 10:50am | 1482POINT ROBERTS, Wash., May 20,2011 - www.InvestorIdeas.com, a leader in investor research including biotech and stem cell stocks, issues a Q&A with Dr. James Musick, Chief Executive Officer of stem cell company, Vitro Diagnostics, Inc. dba Vitro Biopharma (OTCQB: VODG). Q Investorideas.com...